Evidence map›Paper›PMID 30984628›Full record

ArticleFrontiers in cellular and infection microbiology2019

Protease Activity of

Anna-Maria Schmidt, Ulrike Escher, Soraya Mousavi, Manja Boehm, Steffen Backert, Stefan Bereswill, Markus M Heimesaat

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
3.3field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 28 citations in OpenAlex.

  1. Review
  2. ComparingGut microbes · 2025
    Article
  3. Article
  4. Review
  5. Therapeutic and protective approaches to combatFrontiers in pharmacology · 2025
    Review
  6. Cells · 2024
    Article
  7. Investigating the role of aFrontiers in oral health · 2024
    Article
  8. Review
  9. Molecular Targets inBiomolecules · 2023
    Review
  10. Review
  11. Biomolecules · 2022
    Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Novel ClinicalMicroorganisms · 2020
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Anna-Maria SchmidtInstitute of Microbiology, Infectious Diseases and Immunology, Charité - University Medicine Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, Berlin, Germany.
Ulrike EscherInstitute of Microbiology, Infectious Diseases and Immunology, Charité - University Medicine Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, Berlin, Germany.
Soraya MousaviInstitute of Microbiology, Infectious Diseases and Immunology, Charité - University Medicine Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, Berlin, Germany.
Manja BoehmDepartment of Biology, Institute for Microbiology, Friedrich Alexander University Erlangen-Nuremberg, Erlangen, Germany.
Steffen BackertDepartment of Biology, Institute for Microbiology, Friedrich Alexander University Erlangen-Nuremberg, Erlangen, Germany.
Stefan BereswillInstitute of Microbiology, Infectious Diseases and Immunology, Charité - University Medicine Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, Berlin, Germany.
Markus M HeimesaatInstitute of Microbiology, Infectious Diseases and Immunology, Charité - University Medicine Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, Berlin, Germany.
Freie Universität Berlin · DEFriedrich-Alexander-Universität Erlangen-Nürnberg · DEHumboldt-Universität zu Berlin · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Even though human

Indexed as

Host-Pathogen InteractionsAnimalsBacterial LoadBacterial ProteinsCampylobacter InfectionsCampylobacter jejuniDisease Models, AnimalEnterocolitisFecesImmunologic FactorsInterleukin-10Mice, Inbred C57BLMice, KnockoutMutant ProteinsSerine ProteasesVirulence FactorsBacterial ProteinsIL10 protein, mouseImmunologic FactorsInterleukin-10Mutant ProteinsSerine ProteasesVirulence Factorsbacterial translocationCampylobacter jejuniextra-intestinal and systemic immune responseshigh-temperature requirement A (HtrA)host-pathogen-interactionintestinal immunopathologysecondary abiotic IL-10−/− miceserine protease activity

Identifiers

PMID30984628
PMCPMC6449876
OpenAlexW2933187836

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.